SD and VLG performed the experiments and drafted the manuscript, NDS provided clinical samples, VLG and JG designed the study; all authors reviewed and approved the final manuscript. SD was supported by a University of Hull studentship. We would like to thank Mr Jose and other members of the head and neck surgical team in Hull for obtaining the patients’ consent and for collection of peripheral blood samples. The authors declare

BMN 673 ic50 no financial or commercial conflict of interest. “
“Toll-like receptor 4 (TLR4), a key member of the TLR family, has been well characterized by its function in the induction of inflammatory products of innate immunity. However, the involvement of TLR4 in a variety of apoptotic events by an unknown mechanism has been the focus of great interest. Our investigation found that TLR4 promoted apoptotic signalling by affecting the glycogen synthase kinase-3β (GSK-3β) pathway in a serum-deprivation-induced apoptotic paradigm. Serum deprivation induces GSK-3β activation in a pathway that leads to subsequent cell apoptosis. Intriguingly, this apoptotic cascade is amplified in presence of TLR4 but greatly attenuated by β-arrestin 2, another

critical molecule implicated in TLR4-mediated immune responses. Our data suggest that the association of β-arrestin 2 with GSK-3β contributes

Selleck Trametinib to the stabilization of phospho-GSK-3β, an inactive form of GSK-3β. It becomes a critical determinant for the attenuation of TLR4-initiated apoptosis by β-arrestin 2. Taken together, we demonstrate that the TLR4 possesses the capability of accelerating GSK-3β activation thereby deteriorating serum-deprivation-induced apoptosis; β-arrestin 2 represents an inhibitory effect on the TLR4-mediated apoptotic cascade, through controlling the homeostasis of activation and inactivation of GSK-3β. Toll-like receptor AMP deaminase 4 (TLR4), an extensively investigated member of the TLR family, represents the first line of defence against invading pathogens in the innate immune system.1 For conventional TLR4 signalling, it specifically recognizes lipopolysaccharide (LPS) from the outer membrane of Gram-negative bacteria and activates two major signalling pathways, nuclear factor-κB (NF-κB) pathway and mitogen-activated protein kinase pathway, both of which control the expression of key immunoregulatory genes.1 In addition to the widely accepted inflammatory response induced by exogenous infection, activation of TLR4 occurs as a result of non-infectious insults such as hypoxia, ischaemia,2,3 concomitantly with cell damage and apoptosis.